Streetbeat News

Products Services

LOVE

MSFT

Lovesac and Xbox have partnered for a second year to offer an exclusive Cyber Monday deal featuring Lovesac's StealthTech with invisible surround sound technology, aiming to enhance the gaming experience for the holiday season.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:06 pm

DOGEUSD

Crypto analyst Tony 'The Bull' identified a technical signal in Dogecoin's price activity, the one-month Parabolic Stop and Reverse (SAR), which he believes could precede a significant rally similar to a past 23,000% increase. Another analyst, Crypto Tony, also suggested a potential rally based on technical indicators and accumulation patterns. Currently, Dogecoin is trading at $0.076, down 5.38% over the last 24 hours.

Portfolio Pulse from Mehab Qureshi

November 21, 2023 | 2:05 pm

ATIF

ATIF Holdings Limited (NASDAQ:ATIF) has announced that its subsidiary, ATIF Business Management LLC, has signed an $800,000 listing advisory services agreement with a U.S.-based electronic technology innovation company. The services include guiding the client through the IPO process with various support services such as audit, valuation, and investor relations. ATIF's CEO, Liu Jun, expressed commitment to client success and the establishment of a strong cooperative relationship.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:02 pm

AMZN

C3 AI has announced the AWS Marketplace listing of its no-code, self-service generative AI application, C3 Generative AI: AWS Marketplace Edition. Starting November 29, select customers can access a 14-day free trial via private preview. The application is designed to transform enterprise work by enabling users to easily find information and insights within data. It will be publicly available to all AWS customers soon and is already deployed in various industries. All C3 AI products run on AWS and utilize AWS's AI/ML capabilities, including Amazon Bedrock.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:02 pm

CMCSA

INTC

AI21 has completed a $208 million Series C funding round, reaching a valuation of $1.4 billion with investments from Intel Capital and Comcast Ventures. This funding increases AI21's total capital to $336 million, aiming to accelerate the adoption of AI-first enterprise solutions. Intel Capital's Anthony Lin highlighted AI21's full-stack offering, while AI21's co-CEO Ori Goshen emphasized the importance of catering to enterprises' specific needs.

Portfolio Pulse from Anusuya Lahiri

November 21, 2023 | 2:00 pm

HRST

LLY

MASI

MDGL

NVO

PFE

Tema has launched the Tema Cardiovascular and Metabolics ETF (HRST) focusing on companies like Novo Nordisk (NVO), which makes Ozempic, and Eli Lilly (LLY), maker of Mounjaro. Semaglutides, including Ozempic and Mounjaro, have shown significant weight loss and organ protection benefits. NVO's stock has surged 281% since Ozempic's 2019 launch, while LLY's shares jumped nearly 80% post-Mounjaro's 2022 launch. In contrast, Pfizer (PFE), without a semaglutide, has seen a 51% decline since December 2021. HRST aims to capitalize on the lucrative cardiovascular and obesity treatment market, also including companies like Masimo (MASI) and Madrigal Pharmaceuticals (MDGL).

Portfolio Pulse from Neil Dennis

November 21, 2023 | 1:55 pm

ANGH

DKS

SHOT

Dick's Sporting Goods reported an increase in Q3 adjusted EPS to $2.85 from $2.60 year-over-year, with sales rising to $3.04B from $2.96B. Anghami received a commitment for up to $50M cash investment from OSN Group at a valuation of $3.65 per share, which will give OSN a majority stake. Safety Shot announced a West Coast launch in California on December 7th.

Portfolio Pulse from ryanfaloona@benzinga.com

November 21, 2023 | 1:49 pm

BIDU

FXI

SPY

Baidu's CEO anticipates that U.S. sanctions will affect China's AI development in the long term. During a conference call, the CEO mentioned that Baidu is actively looking for alternatives to mitigate the impact of these sanctions.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 1:41 pm

DXC

HBI

DXC Technology (NYSE:DXC) has signed a five-year contract with HanesBrands (NYSE:HBI) to enhance the work experience of HanesBrands' global workforce through Modern Workplace solutions. The partnership, an extension of their existing multi-year global collaboration, will leverage ServiceNow and DXC UPTimeTM Device Management technologies to improve productivity, connectivity, and efficiency across HanesBrands' operations in 32 countries. The digital transformation aims to facilitate better collaboration among HanesBrands' 51,000 associates worldwide and drive business growth by becoming a more digital and data-driven enterprise.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 1:34 pm

JAGX

Napo Pharmaceuticals, part of Jaguar Health, Inc. (NASDAQ:JAGX), has announced that top line data from its Phase 3 OnTarget trial for crofelemer, a drug for preventing diarrhea in cancer patients, is forthcoming. The trial results are still blinded to the company and key personnel. The trial's abstract has been accepted for presentation at the San Antonio Breast Cancer Symposium in December 2023. Crofelemer is a plant-based drug approved under FDA botanical guidance, and the trial aims to address the unmet need for treatment of chemotherapy-induced overactive bowel (CIOB).

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 1:33 pm